Cardinal Health, Inc. · NYSE:CAH

Cardinal Health — Investor Presentation (June 2007)

13 slides from Cardinal Health's investor presentation, Jun 27, 2007

  1. Slide 1: FY2008 Annual Guidance Review

    Exhibit 99.02 FY2008 Annual Guidance Review June 27, 2007

  2. Slide 2: Forward-Looking Statements and GAAP Reconciliation

    Forward-Looking Statements and GAAP Reconciliation Except for historical information, all other information in this presentation consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements are subject

  3. Slide 3: Today's Agenda

    Today’s Agenda Opening remarks Kerry Clark Chief Executive Officer Guidance Review Jeff Henderson Chief Financial Officer Q&A 3

  4. Slide 4: One Cardinal Health

    One Cardinal Health Healthcare Supply Chain Services Clinical and Medical Products HSCS - HSCS – Medical Clinical Technologies Medical Products Pharmaceutical & Services Manufacturing Improving the delivery and Making healthcare safer and economics of healthcare more productive 4

  5. Slide 5: Guidance Overview

    Guidance Overview • FY 2007 Update • FY 2008 Outlook • FY 2008 Financial Targets and Goals 5

  6. Slide 6: FY07 Update

    FY07 Update 1 • Expect FY07 to be in the top end of current guidance: $3.32 – $3.40 CTS: Very strong finish to the year with clear momentum for FY08 MPM: Q4 marks return to strong performance seen in the first half HSCS – P: Q4 revenue up ~6% with flat to declining profitability due to difficult com

  7. Slide 7: FY08 Outlook

    FY08 Outlook 1 • No change to current FY08 EPS guidance: $3.95 – $4.15 – Includes approximately $0.40 EPS benefit from PTS proceeds related share repurchase (Net impact from PTS sale >$0.30 vs. FY07) – Includes up to $0.10 dilution from Viasys acquisition – Includes approximately $0.05 negative impa

  8. Slide 8: Other Assumptions for FY08

    Other Assumptions for FY08 • $4.1B in planned share buyback expected to be complete by Q1 FY08; approximately $3.7B repurchased to date • Up to $1B in additional core share repurchase expected Q2-Q4; subject to Board approval • High share issuances planned for FY08 due to above historical average op

  9. Slide 9: EPS Growth Reconciliation

    EPS Growth Reconciliation FY'07 FY'08 (1) Non-GAAP EPS (In the top end of range) $3.32 - $3.40 $3.95 - $4.15 Includes: Impact of PTS Proceeds 0.08 ~ 0.40 CAH Foundation Contribution (0.05) - Interest Expense Classified as PTS Disc.Ops. 0.05 - Viasys Dilution (up to $0.10) (-) Up to (0.10) (2) Intere

  10. Slide 10: FY 2008 Financial Targets & Goals

    FY 2008 Financial Targets & Goals As of June 27, 2007 Long-Term Financial Goals One Year Targets Over FY'08 - FY'10 3 Year Period: Fiscal Year 2008 Revenue: + 8 - 10% In range 1 Op Earnings : + 10 - 13% At or above top end of range EPS 2 : + 12 - 16% Above range ($3.95 - $4.15 per share3 ) Segment F

  11. Slide 11: Q&A

    Q&A 11

  12. Slide 12: CardinalHealth

    Se CardinalHealth

  13. Slide 13: GAAP/Non-GAAP Reconciliation

    GAAP/Non-GAAP Reconciliation Forward-Looking Non-GAAP Financial Measures The Company presents non-GAAP operating earnings, non-GAAP diluted EPS from continuing operations and non-GAAP return on equity on a forward-looking basis. The most directly comparable forward-looking GAAP financial measures ar

Cardinal Health — Investor Presentation (June 2007) on 6ix